Monthly Archives: April 2019
Veterans with gastroesophageal reflux disease needed for study
Employee Health and Fitness Day celebration is tomorrow
VUMC named among “100 great hospitals in America”
Becker’s Hospital Review has once again named Vanderbilt University Medical Center as one of the “100 great hospitals in America.” Continue reading
“Journey to a Healthy Life” presentation is May 2 in Light Hall
Study merges big data and zebrafish biology to reveal mechanisms of human disease
In a series of studies that volleyed between large databases and research in zebrafish, Vanderbilt investigators have discovered a link between vascular biology and eye disease. Continue reading
Asian nations in early tobacco epidemic: study
Asian countries are in the early stages of a tobacco smoking epidemic with habits mirroring those of the United States from past decades, setting the stage for a spike in future deaths from smoking-related diseases. Continue reading
Limited Submission Opportunity: 2019 Mallinckrodt Grant Program
Developing Pharmacologic Treatments for Eosinophilic Esophagitis: Draft Guidance from the United States Food and Drug Administration
Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease
Polycystic liver disease is the most common extra-renal manifestation of autosomal dominant polycystic kidney disease (ADPKD). There is need for robust long-term evidence for the volume-reducing effect of somatostatin analogues. We made use of data fro… Continue reading
Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome
Little is known about the link between pathophysiologic factors and symptoms of irritable bowel syndrome (IBS), or whether these factors have cumulative effects on patient-reported outcomes (PROs). We investigated whether pathophysiologic alterations a… Continue reading